Clearstead Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $366K | Sell |
|
|||||
|
2025
Q1 | $352K | Buy |
|
|||||
|
2024
Q4 | $261K | Hold |
|
|||||
|
2024
Q3 | $305K | Hold |
|
|||||
|
2024
Q2 | $270K | Buy |
|
|||||
|
2024
Q1 | $16.5K | Sell |
|
|||||
|
2023
Q4 | $157K | Sell |
|
|||||
|
2023
Q3 | $1.07M | Buy |
|
|||||
|
2023
Q2 | $288K | Hold |
|
|||||
|
2023
Q1 | $304K | Buy |
|
|||||
|
2022
Q4 | $358K | Hold |
|
|||||
|
2022
Q3 | $302K | Sell |
|
|||||
|
2022
Q2 | $663K | Buy |
|
|||||
|
2022
Q1 | $736K | Buy |
|
|||||
|
2021
Q4 | $527K | Buy |
|
|||||
|
2021
Q3 | $566K | Hold |
|
|||||
|
2021
Q2 | $509K | Hold |
|
|||||
|
2021
Q1 | $424K | Hold |
|
|||||
|
2020
Q4 | $390K | Hold |
|
|||||
|
2020
Q3 | $437K | Hold |
|
|||||
|
2020
Q2 | $444K | Hold |
|
|||||
|
2020
Q1 | $327K | Hold |
|
|||||
|
2019
Q4 | $346K | Hold |
|
|||||
|
2019
Q3 | $241K | Hold |
|
|||||
|
2019
Q2 | $218K | Hold |
|
|||||
|
2019
Q1 | $280K | Hold |
|
|||||
|
2018
Q4 | $219K | Hold |
|
|||||
|
2018
Q3 | $263K | Hold |
|
|||||
|
2018
Q2 | $295K | Hold |
|
|||||
|
2018
Q1 | $357K | Hold |
|
|||||
|
2017
Q4 | $381K | Hold |
|
|||||
|
2017
Q3 | $352K | Hold |
|
|||||
|
2017
Q2 | $239K | Buy |
|